Ardevora Asset Management LLP Abbott Laboratories Transaction History

Ardevora Asset Management LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	BUY	$95.06 - $111.52 $15.3 Million - $18 Million	161,106 Added 22.28%	884,291 $97.1 Million
Q3 2022 Nov 04, 2022	BUY	$96.76 - $112.03 $19.7 Million - $22.8 Million	203,337 Added 39.11%	723,185 $70 Million
Q2 2022 Jul 11, 2022	SELL	$102.07 - $123.37 $469,521 - $567,502	-4,600 Reduced 0.88%	519,848 $56.5 Million
Q1 2022 Apr 28, 2022	SELL	$114.02 - $139.04 $7.96 Million - $9.71 Million	-69,852 Reduced 11.75%	524,448 $62.1 Million
Q4 2021 Jan 31, 2022	BUY	$115.53 - $141.46 $68.7 Million - $84.1 Million	594,300 New	594,300 $83.6 Million

3,247

1.31B

8.71M

8.02M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Ardevora Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Ardevora Asset Management LLP with notifications on news.